Our scientific advisors

Our Grant Review Board ensure that we only fund the best research that will take us closer to effective diagnostics, preventions and treatments for dementia.

Grant Review Board

Our Grant Review Board ensure that we only fund the best research that will take us closer to effective diagnostics, preventions and treatments for dementia.

We are currently recruiting new researchers to join our Grant Review Board. Find out more information here.

Our scientific advisors

Dr Alexander Gerhard

Dr Gerhard is a clinician based at the University of Manchester. He wants to understand the correlation between clinical symptoms and other aspects of neurodegenerative disease, particularly inflammation.

Bettina Platt

Prof Bettina Platt

Prof Platt is based at the University of Aberdeen. Her research focuses on trying to understand the biological pathways triggered when nerve cells are damaged in Alzheimer’s.

Robert Williams

Dr Robert Williams

Dr Williams is based at the University of Bath and is interested in the break-down in communication between nerve cells and how this can be stopped.

Our scientific advisors

Prof David Brooks

Prof Brooks is a clinician based at Imperial College London. He wants to develop better brain imaging tools to help diagnose dementia.

Our scientific advisors

Dr Delphine Boche

Dr Boche is based at the University of Southampton and researches how inflammation in the brain is altered in dementia.

Lesley Jones

Prof Lesley Jones

Prof Jones is based at the University of Cardiff. Her work involves understanding the biological pathways altered by different genetic risk factors for Alzheimer’s. Prof Jones leads the Alzheimer’s Research UK Cardiff Research Network.

Our scientific advisors

Prof Stephen Wharton

Prof Wharton is based at the University of Sheffield. He is interested in the physical changes that occur in the brain associated with ageing and dementia.

Our scientific advisors

Dr Wendy Noble

Dr Noble is based at King’s College London. She researches nerve cell damage and how the brain’s support cells can affect this.

Tara Spiers-Jones

Dr Tara Spires-Jones

Dr Spires-Jones is based at the University of Edinburgh. She studies how toxic proteins in Alzheimer’s disrupt nerve cell communication.

Johannes Atternes

Prof Johannes Attems

Prof Attems is based at the University of Newcastle. He uses donated brain tissue to understand more about the biological changes that occur in Alzheimer’s. You can learn more about brain donation on the blog.

Our scientific advisors

Dr John-Paul Taylor

Dr Taylor is a clinician based at Newcastle University. He is interested in mechanisms causing cognitive changes in neurodegenerative diseases as well as developing new biomarkers.

Our scientific advisors

Dr Katie Lunnon

Dr Lunnon is based at the University of Exeter. Her work focuses on the genetics underpinning dementia. She uses computational techniques to better understand complex genetic interactions. Dr Lunnon co-chairs the Alzheimer’s Research UK South West Research Network.

Jill Richardson

Dr Jill Richardson

Dr Richardson is a Director at the pharmaceutical company GlaxoSmithKline. She oversees the development of drugs for Alzheimer’s.

Our scientific advisors

Dr David Llewellyn

Dr Llewellyn is based at the University of Exeter. He is interested in how lifestyle factors increase dementia risk.

Simon Mead

Prof Simon Mead

Prof Mead is a clinician based at University College London. His work focuses on the genetics underpinning different forms of dementia.

Michael Coleman

Dr Michael Coleman

Prof Coleman is based at the University of Cambridge. He researches nerve cell damage and how the transport of biological molecules changes with age. He also leads the Alzheimer’s Research UK Cambridge Research Network.

Our scientific advisors

Professor Patricia Salinas

Professor Salinas is based at University College London. She researches how nerve cells communicate and how this can be disrupted in disease.

Our scientific advisors

Dr Mike O'Neill

Dr O’Neill is Head of the Neurodegeneration Group at the pharmaceutical company Lily. He leads a group of researchers investigating new treatments for Alzheimer’s.

Our scientific advisors

Dr Jody Mason

Dr Mason is based at the University of Bath. He is interested in understanding how proteins work and how they can go wrong in disease.